Archive for May, 2009

New Clinics on the Horizon

Tuesday, May 26th, 2009

Cellulogix International is proud to announce that several clinics in Europe are scheduled to be operational by the end of 2009.

Clinics will open later this year in:

  • Berlin, Germany
  • St. Petersburg, Russia
  • London, Englad

For more information contact us.

Opening Soon!

Tuesday, May 26th, 2009

Cellulogix International will soon be operating from clinics in:

  • Bangkok, Thailand
  • Belgrade, Serbia
  • Podgorica, Montenegro

For more information contact us.

Apheresis

Monday, May 11th, 2009

What is Apheresis?

Apheresis is the process of extracting blood components from the peripheral blood with the help of an apheresis machine. This machine is a centrifuge that separates blood into its components on the basis of weight. The machine can be used to obtain plasma (the liquid of the blood), platelets, white cells or Stem Cells. For stem cell transplantation, the cells are collected during the apheresis procedures. Stem cells are mother cells from which several different types of cells arise. When stem cells are infused into a patient’s bloodstream, they will travel to various organs and begin producing cells that eventually mature into organ cells.

How is Stem Cell Apheresis Done?

During apheresis, the patient is connected to the apheresis machine. A needle is inserted into a vein in the arm. Blood is withdrawn from one arm and run through the machine to extract the stem cells.


What Are Possible Complications?

The actual apheresis process is painless. Patients may experience some lightheadedness, numbness or tingling of the nose, lips, or fingers, but these symptoms are short-lived and easily treatable. Each apheresis procedure takes three to four hours. Possible complications include bleeding at the needle sites, clotting in blood vessels used for collection (thrombosis), or surgical complications if a temporary apheresis catheter needs to be inserted. Since the procedure involves penetrating the skin, and open access to blood vessels, infection is always a risk.

Why Peripheral Blood Stem Cells?

There are several reasons and advantages for using peripheral blood stem cells (PBSC) instead of bone marrow for transplantation. Sometimes PBSC are used to add to the stem cells collected from a bone marrow harvest. Other times, a patient’s bone marrow may be contaminated with cancerous cells; PBSC are then used in the hope that these cells are not similarly contaminated. Prior radiation to the pelvic area, or chemotherapy, can also reduce the number of stem cells available for bone marrow harvest. Also, PBSC can be collected without the use of general anesthesia, and the procedure is usually performed on an outpatient basis with little or no discomfort during, or after, the collection. Most importantly, more stem cells can often be collected from the peripheral blood than from the bone marrow. As a result, blood count recovery is faster after PBSC transplant than after bone marrow transplant. This faster recovery translates into lower risk for the patient and fewer complications.

Patent Filings

Monday, May 11th, 2009

Cellulogix International has filed provisional patent applications for the following:

  • Application #61146198 stem cell cocktail for Anti-Aging

  • Application #61146200 stem cell cocktail for Arthritis

  • Application #61146203 stem cell cocktail for Chronic Obstructive Pulmonary Disease

  • Application #61146206 stem cell cocktail for Crohn’s Disease

  • Application #61146212 stem cell cocktail for Type I And II Diabetes

  • Application #61146215 stem cell cocktail for Coronary Disease

  • Application #61146220 stem cell cocktail for Kidney Failure

  • Application #61146226 stem cell cocktail for Liver Diseases

  • Application #61146227 stem cell cocktail for Lupus

  • Application #61146229 stem cell cocktail for Multiple Sclerosis

  • Application #61146232 stem cell cocktail for Parkinson’s